Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HCA Healthcare, Inc.HCA · Entity 2929 | 10% owner | February 06, 2026 | February 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HCA Healthcare, Inc.
Report date February 06, 2026 · Filed February 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | IndirectBy Frisco Holding II | 0 |
Reported balance
After 2026-02-06 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-02-06 · Other · Disposed 36,629,188 · Balance 0 F1: On February 6, 2026, Frisco Holding II ("Frisco") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share ("Shares"), of HCA Healthcare, Inc. (the "Issuer"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended. |
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | IndirectBy Frisco Holding II | 36,557,141 |
Reported balance
After 2026-02-06 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-02-06 · Other · Acquired 36,557,141 · Balance 36,557,141 F1: On February 6, 2026, Frisco Holding II ("Frisco") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share ("Shares"), of HCA Healthcare, Inc. (the "Issuer"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended. F2: Frisco holds 36,557,141 Shares. Frisco is held by a private investor group, including affiliates of the Reporting Person. The Reporting Person may be deemed to exercise voting and investment control over the Shares held by Frisco, but disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein, which may be deemed to include indirect interests in Shares through ownership of Frisco partnership units to the extent of 846,050 Shares by the Reporting Person. |
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 478,955 |
Reported balance
Holding disclosure · report date 2026-02-06 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 478,955 |
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | IndirectBy Hercules Holding II | 32,282,889 |
Reported balance
Holding disclosure · report date 2026-02-06 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 32,282,889 F3: Hercules Holding II ("Hercules") holds 32,282,889 Shares. Hercules is held by a private investor group, including affiliates of the Reporting Person. The Reporting Person may be deemed to exercise voting and investment control over the Shares held by Hercules, but disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein, which may be deemed to include indirect interests in Shares through ownership of Hercules partnership units to the extent of: 540,331 Shares by the Reporting Person; and 72,589 Shares by trusts for the benefit of the Reporting Person of which the Reporting Person is trustee. |
Filing footnotes · ownership attribution and instrument terms
F1: On February 6, 2026, Frisco Holding II ("Frisco") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share ("Shares"), of HCA Healthcare, Inc. (the "Issuer"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended.
F2: Frisco holds 36,557,141 Shares. Frisco is held by a private investor group, including affiliates of the Reporting Person. The Reporting Person may be deemed to exercise voting and investment control over the Shares held by Frisco, but disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein, which may be deemed to include indirect interests in Shares through ownership of Frisco partnership units to the extent of 846,050 Shares by the Reporting Person.
F3: Hercules Holding II ("Hercules") holds 32,282,889 Shares. Hercules is held by a private investor group, including affiliates of the Reporting Person. The Reporting Person may be deemed to exercise voting and investment control over the Shares held by Hercules, but disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein, which may be deemed to include indirect interests in Shares through ownership of Hercules partnership units to the extent of: 540,331 Shares by the Reporting Person; and 72,589 Shares by trusts for the benefit of the Reporting Person of which the Reporting Person is trustee.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 06, 2026 Filed Feb 10, 2026 20:05 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | OtherCommon Stock, par value $0.01 per share | 36,557,141 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-26-004686 · form4.xml · nonDerivative · entry 2 FRIST THOMAS F JR · CIK 0000900596 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Frisco Holding II Disclosed balance after: 36,557,141 F1 · kind: On February 6, 2026, Frisco Holding II ("Frisco") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share ("Shares"), of HCA Healthcare, Inc. (the "Issuer"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended. F1 · price: On February 6, 2026, Frisco Holding II ("Frisco") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share ("Shares"), of HCA Healthcare, Inc. (the "Issuer"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended. F1 · ownership.nature: On February 6, 2026, Frisco Holding II ("Frisco") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share ("Shares"), of HCA Healthcare, Inc. (the "Issuer"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended. F2 · ownership.nature: Frisco holds 36,557,141 Shares. Frisco is held by a private investor group, including affiliates of the Reporting Person. The Reporting Person may be deemed to exercise voting and investment control over the Shares held by Frisco, but disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein, which may be deemed to include indirect interests in Shares through ownership of Frisco partnership units to the extent of 846,050 Shares by the Reporting Person. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 20:05 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | OtherCommon Stock, par value $0.01 per share | 36,629,188 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-26-004686 · form4.xml · nonDerivative · entry 1 FRIST THOMAS F JR · CIK 0000900596 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Frisco Holding II Disclosed balance after: 0 F1 · kind: On February 6, 2026, Frisco Holding II ("Frisco") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share ("Shares"), of HCA Healthcare, Inc. (the "Issuer"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended. F1 · price: On February 6, 2026, Frisco Holding II ("Frisco") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share ("Shares"), of HCA Healthcare, Inc. (the "Issuer"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended. F1 · ownership.nature: On February 6, 2026, Frisco Holding II ("Frisco") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share ("Shares"), of HCA Healthcare, Inc. (the "Issuer"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended. Read SEC document |
| May 02, 2022 Filed May 4, 2022 17:52 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | PurchaseCommon Stock, par value $0.01 per share | 7,577 | $215.29 | $1,631,278.85 |
DisclosureSEC source: 0001209191-22-027202 · doc4.xml · nonDerivative · entry 7 FRIST THOMAS F JR · CIK 0000900596 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 478,955 F7 · price: The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $215.05 to $215.71, inclusive. The Reporting Person undertakes to provide HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| May 02, 2022 Filed May 4, 2022 17:52 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | PurchaseCommon Stock, par value $0.01 per share | 12,170 | $214.48 | $2,610,270.28 |
DisclosureSEC source: 0001209191-22-027202 · doc4.xml · nonDerivative · entry 6 FRIST THOMAS F JR · CIK 0000900596 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 471,378 F6 · price: The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $214.00 to $214.97, inclusive. The Reporting Person undertakes to provide HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| May 02, 2022 Filed May 4, 2022 17:52 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | PurchaseCommon Stock, par value $0.01 per share | 7,683 | $213.47 | $1,640,066.96 |
DisclosureSEC source: 0001209191-22-027202 · doc4.xml · nonDerivative · entry 5 FRIST THOMAS F JR · CIK 0000900596 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 459,208 F5 · price: The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $213.02 to $213.98, inclusive. The Reporting Person undertakes to provide HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| May 02, 2022 Filed May 4, 2022 17:52 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | PurchaseCommon Stock, par value $0.01 per share | 3,606 | $212.60 | $766,631.63 |
DisclosureSEC source: 0001209191-22-027202 · doc4.xml · nonDerivative · entry 4 FRIST THOMAS F JR · CIK 0000900596 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 451,525 F4 · price: The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $212.06 to $212.97, inclusive. The Reporting Person undertakes to provide HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| May 02, 2022 Filed May 4, 2022 17:52 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | PurchaseCommon Stock, par value $0.01 per share | 16,313 | $211.22 | $3,445,589.45 |
DisclosureSEC source: 0001209191-22-027202 · doc4.xml · nonDerivative · entry 3 FRIST THOMAS F JR · CIK 0000900596 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 447,919 F3 · price: The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $211.00 to $211.89, inclusive. The Reporting Person undertakes to provide HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| May 02, 2022 Filed May 4, 2022 17:52 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | PurchaseCommon Stock, par value $0.01 per share | 37,623 | $210.60 | $7,923,403.80 |
DisclosureSEC source: 0001209191-22-027202 · doc4.xml · nonDerivative · entry 2 FRIST THOMAS F JR · CIK 0000900596 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 431,606 F2 · price: The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $210.00 to $210.99, inclusive. The Reporting Person undertakes to provide HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| May 02, 2022 Filed May 4, 2022 17:52 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | PurchaseCommon Stock, par value $0.01 per share | 4,128 | $209.73 | $865,760.49 |
DisclosureSEC source: 0001209191-22-027202 · doc4.xml · nonDerivative · entry 1 FRIST THOMAS F JR · CIK 0000900596 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 393,983 F1 · price: The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $209.40 to $209.97, inclusive. The Reporting Person undertakes to provide HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| August 12, 2020 Filed Feb 16, 2021 17:30 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock, par value $0.01 per share | 28,522.7489 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-010856 · doc5.xml · nonDerivative · entry 1 FRIST THOMAS F JR · CIK 0000900596 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held indirectly through Hercules Holding II by Patricia Champion Frist May 2018 GRAT Disclosed balance after: 0 F1 · ownership.nature: The Reporting Person is trustee of (i) the Thomas F. Frist GST Tax Exempt Trust, (ii) the Patricia Champion Frist May 2019 Grantor Retained Annuity Trust, (iii) the Patricia Champion Frist August 2019 Grantor Retained Annuity Trust, (iv) the Patricia Champion Frist 2020 Grantor Retained Annuity Trust and (v) the Patricia Champion Frist May 2018 Grantor Retained Annuity Trust and may be deemed to be the beneficial owner of the units of Hercules Holding II ("Hercules") held by these trusts and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc. F2 · ownership.nature: Hercules holds 68,912,077 shares of common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein. Read SEC document |
| August 20, 2019 Filed Feb 14, 2020 16:45 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock, par value $0.01 per share | 945.7049 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-009709 · doc5.xml · nonDerivative · entry 2 FRIST THOMAS F JR · CIK 0000900596 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held indirectly through Hercules Holding II by Patricia Champion Frist May 2017 GRAT Disclosed balance after: 0 F2 · ownership.nature: Hercules Holding II ("Hercules") holds 68,912,077 shares of common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein. F3 · ownership.nature: The Reporting Person's spouse is trustee of the Patricia Champion Frist May 2017 Grantor Retained Annuity Trust, and the Reporting Person may therefore be deemed to be the beneficial owner of the units of Hercules held by this trust and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc. Read SEC document |
| May 21, 2019 Filed Feb 14, 2020 16:45 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock, par value $0.01 per share | 48,027.0003 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-009709 · doc5.xml · nonDerivative · entry 1 FRIST THOMAS F JR · CIK 0000900596 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held indirectly through Hercules Holding II by Patricia Champion Frist 2017 GRAT Disclosed balance after: 0 F1 · ownership.nature: The Reporting Person is trustee of (i) the Patricia Champion Frist 2017 Grantor Retained Annuity Trust, (ii) the Thomas F. Frist GST Tax Exempt Trust, (iii) the Patricia Champion Frist May 2018 Grantor Retained Annuity Trust, (iv) the Patricia Champion Frist May 2019 Grantor Retained Annuity Trust and (v) the Patricia Champion Frist August 2019 Grantor Retained Annuity Trust and may be deemed to be the beneficial owner of the units of Hercules held by these trusts and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc. F2 · ownership.nature: Hercules Holding II ("Hercules") holds 68,912,077 shares of common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 18:01 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock, par value $0.01 per share | 66,504 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-012568 · doc4.xml · nonDerivative · entry 2 FRIST THOMAS F JR · CIK 0000900596 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held indirectly through Hercules Holding II by Patricia Champion Frist 2016 GRAT Disclosed balance after: 0 F2 · ownership.nature: Hercules Holding II ("Hercules") holds 68,912,077 shares of common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein. F3 · ownership.nature: The Reporting Person's spouse is the trustee of (i) Patricia Champion Frist 2016 Grantor Retained Annuity Trust and (ii) Patricia Champion Frist May 2017 Grantor Retained Annuity Trust, and the Reporting Person may therefore be deemed to be the beneficial owner of the units of Hercules held by these trusts and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 18:01 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | PurchaseCommon Stock, par value $0.01 per share | 28,650 | $101.07 | $2,895,681.29 |
DisclosureSEC source: 0001209191-18-012568 · doc4.xml · nonDerivative · entry 1 FRIST THOMAS F JR · CIK 0000900596 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 389,855 F1 · price: The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $100.80 to $101.3399, inclusive. The Reporting Person undertakes to provide HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| May 22, 2017 Filed Feb 14, 2018 17:39 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock, par value $0.01 per share | 28,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010031 · doc5.xml · nonDerivative · entry 1 FRIST THOMAS F JR · CIK 0000900596 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held indirectly through Hercules Holding II by Patricia Champion Frist 2015 GRAT Disclosed balance after: 0 F1 · ownership.nature: Hercules Holding II ("Hercules") holds 68,912,077 shares of the common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein. F2 · ownership.nature: The Reporting Person is trustee of (i) Patricia Champion Frist 2015 Grantor Retained Annuity Trust, (ii) Thomas F. Frist GST Tax Exempt Trust and (iii) Patricia Champion Frist 2017 Grantor Retained Annuity Trust and may be deemed to be the beneficial owner of the units of Hercules held by these trusts and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc. Read SEC document |
| May 05, 2017 Filed May 6, 2017 00:07 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | PurchaseCommon Stock, par value $0.01 per share | 1,755 | $84.14 | $147,664.47 |
DisclosureSEC source: 0001209191-17-030463 · doc4.xml · nonDerivative · entry 8 FRIST THOMAS F JR · CIK 0000900596 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 361,205 F8 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $84.06 to $84.21, inclusive. Read SEC document |
| May 05, 2017 Filed May 6, 2017 00:07 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | PurchaseCommon Stock, par value $0.01 per share | 71,850 | $83.47 | $5,997,290.76 |
DisclosureSEC source: 0001209191-17-030463 · doc4.xml · nonDerivative · entry 7 FRIST THOMAS F JR · CIK 0000900596 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 359,450 F7 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $83.15 to $84.04, inclusive. Read SEC document |
| May 04, 2017 Filed May 6, 2017 00:07 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | PurchaseCommon Stock, par value $0.01 per share | 25,421 | $83.58 | $2,124,738.02 |
DisclosureSEC source: 0001209191-17-030463 · doc4.xml · nonDerivative · entry 6 FRIST THOMAS F JR · CIK 0000900596 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287,600 F6 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $83.50 to $83.83, inclusive. Read SEC document |
| May 04, 2017 Filed May 6, 2017 00:07 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | PurchaseCommon Stock, par value $0.01 per share | 73,190 | $82.84 | $6,063,088.88 |
DisclosureSEC source: 0001209191-17-030463 · doc4.xml · nonDerivative · entry 5 FRIST THOMAS F JR · CIK 0000900596 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,179 F5 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $82.61 to $83.49, inclusive. Read SEC document |
| May 04, 2017 Filed May 6, 2017 00:07 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | PurchaseCommon Stock, par value $0.01 per share | 21,989 | $82.40 | $1,811,992.55 |
DisclosureSEC source: 0001209191-17-030463 · doc4.xml · nonDerivative · entry 4 FRIST THOMAS F JR · CIK 0000900596 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,989 F4 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $81.64 to $82.60, inclusive. Read SEC document |
| May 03, 2017 Filed May 6, 2017 00:07 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | PurchaseCommon Stock, par value $0.01 per share | 167,000 | $82.97 | $13,855,155.00 |
DisclosureSEC source: 0001209191-17-030463 · doc4.xml · nonDerivative · entry 3 FRIST THOMAS F JR · CIK 0000900596 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,000 F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $82.66 to $83.05, inclusive. The Reporting Person undertakes to provide HCA Holdings, Inc., any security holder of HCA Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (3), (4), (5), (6) and (7) to this Form 4. Read SEC document |
| February 22, 2017 Filed May 6, 2017 00:07 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock, par value $0.01 per share | 6,657,331.3176 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-030463 · doc4.xml · nonDerivative · entry 2 FRIST THOMAS F JR · CIK 0000900596 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held indirectly through Hercules Holding II by Frist Children's Trust II Disclosed balance after: 0 F1 · ownership.nature: Hercules Holding II ("Hercules") holds 68,912,077 shares of the common stock of HCA Holdings, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist, Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Holdings, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein. F2 · ownership.nature: The Reporting Person's wife is the trustee of (i) Frist Children's Trust, (ii) Frist Children's Trust II and (iii) Patricia Champion Frist 2016 Grantor Retained Annuity Trust, and the Reporting Person may therefore be deemed to be the beneficial owner of the units of Hercules held by these trusts and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Holdings, Inc. Read SEC document |
| February 22, 2017 Filed May 6, 2017 00:07 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock, par value $0.01 per share | 387,659.7546 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-030463 · doc4.xml · nonDerivative · entry 1 FRIST THOMAS F JR · CIK 0000900596 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held indirectly through Hercules Holding II by Frist Children's Trust Disclosed balance after: 0 F1 · ownership.nature: Hercules Holding II ("Hercules") holds 68,912,077 shares of the common stock of HCA Holdings, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist, Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Holdings, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein. F2 · ownership.nature: The Reporting Person's wife is the trustee of (i) Frist Children's Trust, (ii) Frist Children's Trust II and (iii) Patricia Champion Frist 2016 Grantor Retained Annuity Trust, and the Reporting Person may therefore be deemed to be the beneficial owner of the units of Hercules held by these trusts and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Holdings, Inc. Read SEC document |
| February 17, 2016 Filed Feb 14, 2017 22:53 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock, par value $0.01 per share | 74,193 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-010698 · doc5.xml · nonDerivative · entry 1 FRIST THOMAS F JR · CIK 0000900596 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held indirectly through Hercules Holding II by Patricia Champion Frist 2013 GRAT No. 3 Disclosed balance after: 0 F1 · ownership.nature: Hercules Holding II ("Hercules") holds 68,912,077 shares of the common stock of HCA Holdings, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist, Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Holdings, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein. On September 23, 2016, Hercules Holding II, LLC, a Delaware limited liability company, was converted into Hercules Holding II, a Delaware general partnership. F2 · ownership.nature: The Reporting Person is the trustee of (i) Thomas F. Frist GST Tax Exempt Trust, (ii) Patricia Champion Frist 2013 Grantor Retained Annuity Trust No. 3 and (iii) Patricia Champion Frist 2015 Grantor Retained Annuity Trust and may be deemed to be the beneficial owner of the units of Hercules held by these trusts and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Holdings, Inc. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.